13 Background: Potentially modifiable risk factors have been associated with Alzheimer's disease 14 (AD). However, the causality of these risk factors on AD is unclear. Using Mendelian 15 randomization we evaluated the causal effect of potentially modifiable risk factors on AD and its 16 associated endophenotypes to inform the development of lifestyle interventions that could 17 reduce risk of developing AD. 18 Methods and Findings: Genetic instruments for the exposures were selected from genome 19 wide association studies (GWAS) for traits previously linked to AD in observational studies 20 including alcohol intake, physical activity, lipid traits, blood pressure traits, type 2 diabetes, 21 body-mass index (BMI), depression, sleep, social isolation, smoking, oily fish intake, and 22 [1.3, 2.69]) and total cholesterol (OR [CI]: 2.03 [1.44, 2.85]). Genetically predicted insomnia 38 symptoms (β [CI]: -0.2 [-0.34, -0.06]) and total cholesterol were associated (β [CI]: -0.06 [-0.1, -39 0.03]) with hippocampal volume. Potential limitations include weak instrument bias, non-40 homogenous samples and other implicit limitations of MR analysis. 41 Conclusions: Demonstration of a causal relationship between blood pressure, cholesterol 42 levels, BMI, depression, insomnia symptoms, physical activity and educational attainment on 43 the AD phenome strongly support public health programs to educate the public about these 44 preventable causes of AD. 45 46
Introduction 50 Late-onset Alzheimer's disease (AD) is a debilitating neurological condition characterized by 51 progressive deterioration in cognitive function and concomitant functional decline [1] . The 52 primary neuropathological hallmarks of AD are the aggregation of extracellular amyloid-β (Aβ) 53 peptides into amyloid plaques and of intracellular hyperphosphorylated tau into neurofibrillary 54 tau tangles (NFTs), accompanied by gliosis and neurodegeneration [1, 2] . 55 56
In the absence of any pharmacotherapeutic intervention, the number of people living with 57 dementia -of which AD accounts for ~70% of cases -is expected to exceed 130 million by 58 2050 [3] . Observational studies have identified potentially modifiable risk factors that could be 59 targeted in intervention studies to reduce the risk of dementia [4] . From these studies it has 60 been estimated that 35% of AD cases may be attributable to preventable causes such as low 61 educational attainment, hearing loss, hypertension, obesity, smoking depression physical 62 inactivity, social isolation and diabetes [5] . This suggests that interventions that target modifiable 63 risk factors could significantly reduce the population prevalence of AD and related dementias. 64 65 Lifestyle interventions that target modifiable risk factors are entirely dependent on accurate 66 causal relationships being established between modifiable risk factors and AD. In observational 67 studies, a correlation between a risk factor and AD cannot be reliably interpreted as evidence of 68 a causal relationship. First, this can be due to confounding, where some or all of the correlation 69 can be due to a third confounding variable that is correlated to both the putative risk factor and 70 AD. Second, the observed correlation between a risk factor and dementia may be due to 71 reverse causation, where the neurodegenerative and cerebrovascular changes that underlie 72 dementia begin decades before the onset of clinical symptoms. As such, the lifestyle risk factors 73 that are associated with the development of dementia in late-life may themselves be a 74 consequence of the same underlying pathological processes and not a causal factor of 75 dementia. If this is the case, disease reduction strategies targeting modifiable risk factors are 76 unlikely to be successful. 77
78
A novel method for establishing causal relationships between exposures (e.g. modifiable risk 79 factors) and outcomes (e.g. AD) is Mendelian randomization (MR). MR uses genetic variants as 80 proxies for environmental exposures to provide an estimate of the causal association between 81 an intermediate exposure and a disease outcome [6] . MR is similar to a 'genetic randomized 82 control trial' due to the random allocation of genotypes from parents to offspring and is thus not 83 affected by reverse causation and is independent of confounding factors that may influence 84 disease outcomes [6] . MR analysis can be conducted using GWAS summary statistics, taking 85 advantage of the increased samples sizes available in independent GWAS and the increasing 86 number of genetic variants being discovered to increase statistical power [7] . 87
88
In this study we used MR to establish causal relationships between modifiable risk factors and 89 the AD phenome -AD status, AD age of onset survival (AAOS), amyloid-beta 42 (Aβ 42 ), tau and 90 hyperphosphorylated tau (ptau 181 ) levels in cerebrospinal fluid (CSF), the neuropathological 91 burden of neuritic plaques, neurofibrillary tangles and vascular brain injury, and hippocampal 92 volume. Based on these analyses we identified a subset of modifiable risk factors that represent 93 the most promising targets for public health initiatives to reduce AD burden in the population. 94
95
Methods 96
Data Sources 97
We obtained GWAS summary statistics (GWAS-SS) for each exposure and outcome of interest 98 ( T  a  b  l  e  1  :  G  e  n  o  m  e  -w  i  d  e  a  s  s  o  c  i  a  t  i  o  n  s  t  u  d  i  e  s  u  s  e  d  i  n  t  h  i  s  s  t  u  d  y   100   S  t  u  d  y  T  r  a  i  t  C  o  h  o  r  t  /  C  o  n  s  o  r  t  i  u  m  N  A  g  e  F  e  m  a  l 
Genetic Instruments 126
For each exposure, we constructed two instrumental variables (IV) using genome-wide 127 significant (p < 5 x 10 -8 ) and nominally significant (p < 5 x 10 -6 ) loci. Increasing the number of 128 loci in the instrumental variable increases the variance explained by the IV and improves power. 129
However, this can increase the likelihood of bias due to variants violating the core MR 130 assumptions and bias results towards the null by increasing weak instrument bias. To obtain 131 independent SNPs, linkage disequilibrium (LD) clumping was performed by excluding SNPs that 132 had an r2 > 0.001 with another variant with a smaller p-value association within a 1000kb 133 window using PLINK [30] . For genetic variants that were not present in the outcome GWAS, 134 PLINK was used to identify proxy SNPs that were in LD (r 2 > 0.8; EUR reference population). 135
Finally, the exposure and outcome GWAS datasets were harmonized so that the effect size for 136 the exposure and outcome correspond to the same effect alleles. Genetic variants that were 137 palindromic with ambiguous allele frequencies (AF > 0.42) or incompatible alleles were 138 removed. The proportion of variance in the phenotype explained by each instrument and F-139 statistic were calculated as previously described [31, 32] . 140 141
Mendelian Randomization Analysis 142
For each genetic variant, we calculated an instrumental variable ratio estimate by dividing the 143 SNP-exposure by SNP-outcome and coefficients were combined in a fixed-effects meta-144 analysis using an inverse-variance weighted (IVW) approach to give an overall estimate of 145 causal effect [7] . The IVW method assumes that all SNPs included in the causal estimate are 146 valid instruments -that is they do not violate any of the underlying assumptions [7] . In order to 147 account for potential violations of the assumptions underlying the IVW analysis, we conducted 148 sensitivity analysis using alternative MR methods known to be more robust to horizontal 149 pleiotropy, but at the cost of reduced statistical power. The alternative approaches included 1) 150
Weighted Median Estimator (WME), which takes the median effect of all available variants, 151 allowing 50% of variants to exhibit horizontal pleiotropy [33] ; 2) Weighted Mode Based 152 Estimator (WMBE), which clusters variants into groups based on similarity of causal effects and 153 reports the final causal effect based on the cluster with the largest number of variants [34]; and 154
3) MR-Egger regression, which allows all variants to be subject to direct effects [35] . where the sensitivity analyses were also significant and the effect direction was concordant with 167 the IVW results. To account for multiple testing burden, we report q-values, a false discovery 168 rate-based measure of significance [37]. Power analyses were conducted using the non-169 centrality parameter based approach using the observed IVW coefficient [38] . 170 171 All statistical analyses were conducted using R version 3.5.2 [39] . Mendelian randomization 172 analysis was performed using the 'TwoSampleMR' package [40] . A Snakemake workflow was 173 constructed that automates the MR analysis pipeline and allows for multiple exposure -174 outcomes datasets to be run in parallel [41] . 175
176
The SNPs used in each instrument, their harmonized effects and, outliers are presented in S1 177 We conducted a total of 405 tests -9 outcomes, 23 exposures, and 2 P t (alcohol dependence 184 was only run with a P t < 5e-6) -and observed 18 tests that were significant at an FDR < 0.05 185 ( 4
) . Using genetic variants as proxies for modifiable risk factors, this MR analysis is the first to 258 investigate the association of modifiable risk factors with the AD phenome. We found evidence 259 of causal associations for educational attainment, BMI, blood pressure, lipid traits, insomnia 260 symptoms, physical activity, depression, and alcohol consumption, on either AD or its 261 associated endophenotypes. 262 263 Higher educational attainment was causally associated with a reduced risk of AD, which is 264 consistent with previous MR analyses [42-44]. However, a multivariable MR analysis that 265 accounted for intelligence in addition to educational attainment suggests that the relationship 266 between education and AD is largely driven by intelligence [45] . Two of these studies [43,45] 267 used a smaller GWAS of educational attainment that explained less phenotypic variance than 268 the GWAS that was used in this analysis. One study used the same GWAS used in this analysis 269
[46], while the other conducted a single sample MR analysis [44] . The MR analyses are also 270 consistent with the observational literature [47] . We also observed a novel causal association 271 between higher education and delayed AAOS, consistent with the cognitive reserve hypothesis. 272
The observational literature, however, suggests that lower education is associated with delayed 273 age at onset, however, this association is potentially confounded due to the symptoms of AD 274 being recognized later among those with less education [48] . Additionally, we found no evidence 275 that education is causally associated with AD neuropathology or CSF biomarkers, corroborating 276 evidence from observational studies [49] , and supports the hypothesis that education mitigates 277 dementia risk via cognitive reserve rather than affecting AD pathogenesis [50] . 278 279 BMI was causally associated with an earlier AAOS but was not associated with AD risk or other 280 endophenotypes. Previous MR analyses have found that BMI is not a causal risk for AD 281
[43,51,62,63] using smaller GWAS of BMI than used in our analysis, however, no previous MR 282 study has evaluated the causal effect of BMI on age at onset. In contrast, observational studies 283 have observed that a higher midlife BMI is associated with increased risk of dementia, while 284 late-life obesity has an apparent protective effect likely due to reverse causation [64] [65] [66] . 285 Consistent with our AAOS results, midlife obesity is also associated with an earlier age of onset 286
[67]. 287 288 Increased DBP and SBP were causally associated with reduced AD risk, and, in addition to PP, 289 associated with increased risk of VBI. Additionally, higher DBP was associated with reduced 290 CSF tau levels. This corroborates the results from a previous MR analysis based on 24 variants 291 but contradicts those of a more recent MR study that found no evidence of a causal association 292 based on an instrument composed of 105 variants [43, 51] . In contrast to these previous 293 analyses, we selected instruments from a larger GWAS of blood pressure. Based on 294 epidemiological research, high blood pressure in midlife is generally regarded as a risk factor for 295 dementia in midlife while low blood pressure in late-life has been associated with an increased 296 risk of dementia [5,52]. However, systematic reviews and meta-analysis of the role of 297 hypertension in midlife, have observed that hypertension in midlife is associated with an 298 increased risk of developing vascular dementia but not with AD [53-55]. Additionally, 299 randomized control trials in elderly populations using either a pharmacotherapeutic or lifestyle 300 change blood pressure lowering interventions did not significantly reduce the risk of dementia 301
[56]. Our MR analysis also suggests that reducing blood pressure in late life may have limited 302 utility in the prevention of AD, but may reduce the risk of vascular dementia by reducing the risk 303 of VBI. 304 305 Increased LDL-cholesterol and total cholesterol were causally associated with an increased risk 306 of neuritic plaques, corroborating previous observational studies that have reported associations 307 between increased total plasma cholesterol levels and amyloid deposition [57, 58] . We did not 308 observe a causal association with AD risk, which is consistent with three previous MR analysis 309 of lipid traits on the risk of AD [43, 51, 59] . This study and the previous studies all used the same 310 GWAS for selecting instruments associated with lipid traits. However, these results contrast with 311 observational studies that have found higher midlife total cholesterol associated with an 312 increased risk of AD and all-cause dementia, while higher late-life total cholesterol is not 313 associated with all-cause dementia or dementia subtypes [60] . Furthermore, in cognitively intact 314 individuals statins are associated with a reduced risk of all-cause dementia, AD, and MCI, but 315 not VaD [61] . 316 317 Insomnia symptoms were associated with reduced hippocampal volume but not with AD or 318 other AD endophenotypes. Sleep duration was not causally associated with the AD phenome. 319
Observational studies have indicated that sleep disturbances and problems are associated with 320 an increased risk of all-cause dementia, AD and vascular dementia [68, 69] . However, the 321 association between insomnia and hippocampal volume is less established with studies either 322 reporting a positive relationship [70, 71] or no association [72] . The results of this study provide 323 further support for insomnia being causally related to reduced hippocampal volumes and 324 underlines the importance of sleep for brain health. 325
326
Increased MVPA was associated with increased CSF Aβ 42 levels, but also with an increased 327 risk of AD. Increased physical activity is generally associated with a reduced risk of dementia 328
[5], however, a recent meta-analysis found that the protective association with dementia was 329 observed when physical activity was measured <10 years before dementia diagnosis, but when 330 measured >10 years before dementia onset no association with dementia was observed [73] . The results of this study should be interpreted in conjunction with knowledge of its limitations 386 and those of MR in general. Firstly, inference of causality in MR analyses relies on the 387 assumption that the genetic variants used as instruments are strongly associated with the 388 exposure (the non-zero effect assumption). While we cannot exclude that our findings may be 389 affected by weak instrument bias, the F-statistics for all of the analyses were over 10 indicating 390 that the instrument strength was sufficient for MR analysis [32] . However, in Two-Sample MR 391 analyses, weak instrument bias is in the direction of the null, thus, we cannot exclude type II 392 error as an explanation for the null results that had limited power [98] . Second, we cannot 393 completely rule out violations of the independence and the exclusion restriction assumption, 394 particularly in regard to pleiotropy [99] . Nevertheless, we used several methods to identify 395 robust causal estimates, including outlier removal using MR-PRESSO and WMBE, WME and 396 MR-Egger sensitivity analyses. Thirdly, it is assumed that both samples used to generate the 397 GWAS summary statistics used in the MR model come from comparable populations. In 398 evaluating the demographics of the studies used in this analysis, the exposures have an 399 average age ranging from 56.1 -63.8yrs while outcomes, with the exception of hippocampal 400 volume, have an average age ranging from 71 -74.7yrs. As such, some of the results reported 401 here may be subject to survivor bias whereby mortality due to competing risks affects selection 402 into the target study [89] . Nevertheless, the bias introduced by survival effects is large for 403 exposures that strongly affect survival, however, when selection effects are weak or moderate, 404 selection bias does not adversely affect causal estimates [89] . Finally, these analyses were 405 conducted using GWAS from European populations, limiting their generalizability to other 406 populations. Replicating these findings in non-European populations where there is potentially 407 greater variability in the modifiable risk factors remains key. 408 409 Despite these limitations, this study has significant strengths. We assessed the causal effect 410 multiple potential modifiable risk factors on AD endophenotypes in addition to AD risk. In 411 addition, we selected genetic variants for the exposure that originated from the largest available 412 GWAS at the time of analysis, and also the most recent GWAS for AD. By utilizing larger GWAS 413 that previous MR analyses, we were able to include a larger number of instruments that explain 414 a greater proportion of the phenotypic variance of the exposures, resulting in increased the 415 statistical power for this analysis. 416
417
In conclusion, this study used large exposure and outcome GWAS in MR studies to evaluate the 418 causal associations of modifiable risk factors with the AD phenome. We found evidence of 419 causal associations of alcohol consumption, blood pressure, cholesterol traits, educational 420 attainment BMI, hearing problems, insomnia symptoms, physical activity, and depressive 421 symptoms on either AD or its associated endophenotypes. Around 29.5% of dementia cases 422 can be attributed to educational attainment, hypertension, BMI, hearing loss and physical 423 activity. Evidence of causal relationships on the AD phenome strongly supports that This study used published summary results from published research papers, with the references 444 for those studies provided in the main paper. S1 Table provides 
